{"id":116252,"date":"2005-03-29T18:00:00","date_gmt":"2005-03-29T23:00:00","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/new-york-eye-surgeon-chosen-to-implant-restorr-pseudoaccommodative-lens-for-cataract-correction\/"},"modified":"2005-03-29T18:00:00","modified_gmt":"2005-03-29T23:00:00","slug":"new-york-eye-surgeon-chosen-to-implant-restorr-pseudoaccommodative-lens-for-cataract-correction","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/new-york-eye-surgeon-chosen-to-implant-restorr-pseudoaccommodative-lens-for-cataract-correction\/","title":{"rendered":"New York Eye Surgeon Chosen to Implant ReSTOR(R) Pseudoaccommodative Lens for Cataract Correction"},"content":{"rendered":"<p class=\"s2pred\"><strong>NEWS SOURCE: Medical Management Services Group MMSG<\/strong><\/p>\n<p>POUGHKEEPSIE, NY \/Send2Press Newswire\/ &#8212; Satish. S. Modi, M.D., F.R.C.S. ( C ) a leading ophthalmic surgeon in Poughkeepsie, New York has been selected by Alcon Laboratories as one of a limited number of surgeons to begin implanting its AcrySoft(R) ReSTOR(R) Intraocular Lens (IOL) for cataract patients with and without presbyopia. <\/p>\n<p> Dr. Modi has been using the earlier generation AcrySoft(R) lens for many years to correct cataract patients&#8217; distance vision. &#8220;This innovative ReSTOR(R) lens represents a major step forward in the AcrySoft(R) lens implant platform and uses an unique diffractive technology to assist patients in achieving a normal range of vision, so that they are independent of glasses for near, intermediate and distance vision after having cataract surgery,&#8221; said Dr. Modi.<\/p>\n<p> The clinical trials presented to the FDA to obtain approval for the AcrySoft(R) ReSTOR(R) IOL demonstrated that 80% of the patients who had the lens implanted did not use glasses for any activities after their cataract surgery. <\/p>\n<p> Alcon Laboratories, the manufacturer of the lens, received Food and Drug Administration approval of AcrySoft(R) ReSTOR(R) IOL on March 23, 2005 and has selected a limited number of surgeons throughout the United States to begin implanting the lens in May 2005. <\/p>\n<p> &#8220;My commitment to patients is that we should always provide them with the best technology and advances in eye care. I have dedicated my practice to helping patients decrease their dependence on glasses. This lens will help me achieve my goals as well as my patients&#8217; goals in the coming years,&#8221; said Dr. Modi.<\/p>\n<p> More information: <a href=\"http:\/\/www.lasik-new-york.net\">http:\/\/www.lasik-new-york.net<\/a><\/p>\n<p> All trademarks acknowledged.<\/p>\n<p>News issued by: Medical Management Services Group (MMSG)<\/p>\n<p> # # # <\/p>\n<p><small>Original Story ID:  (217) :: 2005-03-0329-007<\/small><\/p>\n<p><small>Original Keywords: Satish. S. Modi, M.D., F.R.C.S., ophthalmic surgeon in Poughkeepsie, New York, AcrySoft ReSTOR Intraocular Lens (IOL), Medical Management Services Group, MMSG, NY News Medical Management Services Group (MMSG)   <\/small><\/p>\n<p class=\"s2pred\"><strong>NEWS SOURCE: Medical Management Services Group MMSG<\/strong> | Published: 2005-03-29 18:00:00<\/p>\n","protected":false},"excerpt":{"rendered":"<p>POUGHKEEPSIE, NY \/Send2Press Newswire\/ &#8212; Satish. S. Modi, M.D., F.R.C.S. ( C ) a leading ophthalmic surgeon in Poughkeepsie, New York has been selected by Alcon Laboratories as one of a limited number of surgeons to begin implanting its AcrySoft(R) ReSTOR(R) Intraocular Lens (IOL) for cataract patients with and without presbyopia.<\/p>\n","protected":false},"author":9780,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"singles-wide.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19937],"tags":[],"class_list":["post-116252","post","type-post","status-publish","format-standard","hentry","category-press-releases-archive","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":620,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/116252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/9780"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=116252"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/116252\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=116252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=116252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=116252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}